Unknown

Dataset Information

0

N-substituted glutamyl sulfonamides as inhibitors of glutamate carboxypeptidase II (GCP2).


ABSTRACT: Glutamate carboxypeptidase II (GCP2) is a membrane-bound cell-surface peptidase which is implicated in several neurological disorders and is also over-expressed in prostate tumor cells. There is a significant interest in the inhibition of GCP2 as a means of neuroprotection, while GCP2 inhibition as a method to treat prostate cancer remains a topic of further investigation. The key zinc-binding functional group of the well-characterized classes of GCP2 inhibitors (phosphonates and phosphoramidates) is tetrahedral and negatively charged at neutral pH, while glutamyl urea class of inhibitors possesses a planar and neutral zinc-binding group. This study introduces a new class of GCP2 inhibitors, N-substituted glutamyl sulfonamides, which possess a neutral tetrahedral zinc-binding motif. A library containing 15 secondary sulfonamides and 4 tertiary (N-methyl) sulfonamides was prepared and evaluated for inhibitory potency against purified GCP2 enzyme activity. While most inhibitors lacked potency at 100 ?m, short alkyl sulfonamides exhibited promising low micromolar potency, with the optimal inhibitor in this series being glutamyl N-(propylsulfonamide) (2g). Lastly, molecular docking was used to develop a model to formulate an explanation for the relative inhibitory potencies employed for this class of inhibitors.

SUBMITTER: Blank BR 

PROVIDER: S-EPMC3055939 | biostudies-literature | 2011 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

N-substituted glutamyl sulfonamides as inhibitors of glutamate carboxypeptidase II (GCP2).

Blank Brian R BR   Alayoglu Pinar P   Engen William W   Choi Joseph K JK   Berkman Clifford E CE   Anderson Marc O MO  

Chemical biology & drug design 20110222 4


Glutamate carboxypeptidase II (GCP2) is a membrane-bound cell-surface peptidase which is implicated in several neurological disorders and is also over-expressed in prostate tumor cells. There is a significant interest in the inhibition of GCP2 as a means of neuroprotection, while GCP2 inhibition as a method to treat prostate cancer remains a topic of further investigation. The key zinc-binding functional group of the well-characterized classes of GCP2 inhibitors (phosphonates and phosphoramidate  ...[more]

Similar Datasets

| S-EPMC3222833 | biostudies-literature
| S-EPMC5516903 | biostudies-literature
| S-EPMC4077459 | biostudies-literature
| S-EPMC4712110 | biostudies-literature
| S-EPMC2706136 | biostudies-literature
| S-EPMC6374116 | biostudies-literature
| S-EPMC2330195 | biostudies-literature
| S-EPMC9976286 | biostudies-literature
| S-EPMC8634091 | biostudies-literature
| S-EPMC19722 | biostudies-literature